Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huimei Healthcare is a China-based healthcare management and medical AI company formed through collaboration between Mayo Clinic and Hillhouse Capital. The group combines healthcare management services with digital-health subsidiaries, including Huimei Technology, which commercializes the Dr.Mayson clinical decision support system and related hospital workflow tools. Its products are used by hospitals for clinical decision support, medical record quality control, DRG/DIP and insurance review, VTE prevention, rare-disease support, and patient education. Huimei positions itself as a hospital-focused smart healthcare platform rather than a drug developer, with broad commercial deployment across large Chinese hospitals. The company also operates adjacent businesses in healthcare investment and digital commercialization under the broader Huimei ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huimei Healthcare.